INS and type 1 diabetes mellitus: Reduction in neurotrophic insulin effects, C-peptide deficiency, and autoimmune-mediated neural damage could represent specific pathogenetic mechanisms for T1DM-related DSPN, whereas it remains largely unexplained why some patients suffer from neuropathic pain.